HIV
Conditions
Interventions
Test Group:HAART+Warming kidney spleen side particles
Control Group:HAART+Placebo
Sponsors
China academy of traditional Chinese medical sciences
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1. Antibody positive, by Western Blot confirmation tests confirmed; 2. HAART=12month; 3. CD4+T-lymphocyte count absolutely rise <100cells/ul compared with the count before HAART,and CD4+T-lymphocyte count absolutely =300cells/ul; 4. aged 18 to 55 years; 5. Accord with spleen and kidney Yang deficiency syndrome diagnostic standard; 6. Volunteered to participate in this study, cognitive agreement signed.
Exclusion criteria
Exclusion criteria: 1. Severe opportunistic infection uncontrol before the group; 2. Patients who participate in other drug clinical trials in 1 month before the group or now; 3. Patients who take in immunomodulatory therapy in 1 month before the group; 4. WBC<2*10^9/L, N<1.0*10^9/L, Hb<90g/L, PLT<75*10^9/L, hepatic and kidney function obstacle (AST, ALT, T-BIL=double of reference value maximum); 5. Patient who have active respiratory system, digestive system and circulatory system, blood system, neuroendocrine system, urogenital system diseases and autoimmune. diseases; 6. cancer patients need to chemotherapy; 7. Allergic constitution; 8. Intelligence or the language barrier, patients who can not fully understand the content, or give a good cooperation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| T lymphocyte proliferation test;T lymphocyte apoptosis detection;CD4+, CD8+, CD45RA+ count;Semeiology indicators; | — |
Countries
China
Contacts
Public ContactYing Liu
China academy of traditional Chinese medical sciences
Outcome results
None listed